Objective: The purpose of this review is to survey the literature regarding factors used in determining a course of surgical treatment for symptomatic cartilage lesions of the knee to determine which factors affect treatment outcomes and should be incorporated in the treatment algorithm.
INTRODUCTION
Focal chondral defects or lesions are commonly seen in knee arthroscopy. 1, 2 These defects vary in thickness, 3 ranging from partial to full. 4 Many chondral defects are asymptomatic and, thus, it is difficult to estimate true incidence or prevalence. In a recent systematic review, more than half of asymptomatic athletes were found to have full-thickness defects. 5 Although the natural history of lesion progression may be unclear, they may eventually cause symptoms and functional impairment. 6 If left untreated, biomechanical overload of the defect may cause further degenerative changes in adjacent tissue and intralesional subchondral bone, leading to progression to osteoarthritis. 7 Current cartilage repair algorithms 6, 8, 9 aim for the optimal treatment to reduce symptoms and restore functionality. These algorithms stress the importance of lesion-specific factors such as size and intra-articular location (patellofemoral or tibiofemoral). Patient knee demand level, as well as other knee-specific comorbidities (meniscal deficiency, mechanical malalignment, ligamentous laxity) also affect treatment choice. Patient-specific factors such as age and physical activity level are also common considerations. [9] [10] [11] [12] [13] Several factors have been found to affect cartilage defect treatment outcomes, yet have not been included in most existing algorithms. For instance, the intra-articular location of the lesion, specifically the medial femoral condyle, has been shown to predict better outcomes of autologous chondrocyte implantation (ACI) and microfracture (MFx) than lateral defects. 14 Higher patient body mass index (BMI) has also been associated with worse outcomes of MFx. 15 Further, female sex has been linked to greater cartilage loss and defect progression. 16 Despite supportive studies regarding the importance of commonly used factors in the algorithm, other evidence regarding the effects of patient-, knee-, and defect-specific factors on cartilage defect treatments exists. There is a need to further identify and characterize these factors and expand and refine the current treatment algorithm. We investigate the patient-related, knee-related, and defect-related factors that may influence cartilage lesion treatment and could be used as criteria in treatment selection. The study hypothesis is that patient age, BMI, sex, defect size and location, and alignment all play a significant role in the outcome of knee cartilage lesion treatment and could be considered in an expanded algorithm.
METHODS
A systematic review of the literature on cartilage defects was conducted using the PubMed, Cochrane Reviews, and SportDiscus databases. The search was performed April 20, 2012, and repeated April 22, to ensure the inclusion of all relevant studies. The key words used for the search included knee cartilage repair, defects, chondral lesions, treatment, algorithm, size, location, shape, mechanics, alignment, gender, sex, BMI, and ethnicity. Included studies were graded as levels I, II, III, IV, or V evidence by the Oxford Centre for Evidence-Based Medicine. 17 The inclusion criteria were the following:
• English language • Clinical outcome and basic science studies • In vivo or cadaveric human or animal subjects • Publication between 1970 and 2012 • Studies reporting treatment outcomes of partial-thickness and full-thickness chondral defects in the knee • Studies reporting treatment outcomes of focal defects, not osteoarthritis.
Exclusion criteria included the following:
• Non-English language • Non-knee joint • Studies reporting treatment outcomes of osteoarthritis.
The initial keyword search in 3 databases yielded a total of 7826 potentially relevant citations. Further screening by the primary author eliminated studies in joints other than the knee and non-English language studies. Figure 1 illustrates how the list was filtered through inclusion/exclusion criteria and narrowed down to 27 studies.
The scope of the search included studies investigating the influence of patient-related (age, sex, BMI), knee-related (tibiofemoral or patellofemoral alignment and menisco-ligamentous status), and lesion-related (surface area, depth, intra-articular location) factors on the choice of treatment of knee chondral defects. Further, studies that reported the association of such factors with tissue biomechanical properties were investigated.
Application of exclusion criteria led to final inclusion of 27 studies [14] [15] [16] for detailed analysis. The 27 studies (21 in vivo and 6 in vitro) examined a total of 1416 human subjects (in vivo), 90 animal subjects (both in vivo and in vitro), and 34 cadavers (in vitro). These included 2 randomized controlled trials (RCTs), 12 prospective cohort studies, 4 retrospective case series, 5 animal experiments, and 4 cadaveric laboratory studies.
RESULTS
Each of the 27 studies investigated the association between patient-specific, knee-specific, and defect-specific factors and various outcomes. The heterogeneity of the selected studies (in terms of study design, outcomes measured, factors studied, and patient populations) prevented performance of a meta-analysis.
Evidence Supporting Factors Currently Considered in Treatment Selection Lesion Size
The evidence, with a variety of study designs, showed an effect of lesion size on cartilage biomechanics (Table 1) . Several biomechanical and animal studies highlighted the importance of defect size and the threshold at which articular cartilage undergoes biomechanical changes. [20] [21] [22] [23] [24] 28 An in vitro canine study showed that lesion size alters circumferential cartilage contact stress levels, which are lower in intact cartilage surface. 20 Other human cadaveric studies showed that peak stress concentration, which may be related to the stability of the cartilage adjacent to defects, was significantly greater (P , 0.05) around the rim of defects that were $10 mm in diameter. Defects #5 mm showed no deviation in contact pressure at the defect from the surrounding healthy tissue. 21, 23, 24 In a separate study, defects 6 mm in diameter did not result in degradation to cartilage that is adjacent to the defects in canine knees after 1 year of follow-up. 22 In a bovine study, lesions larger than 0.97 cm 2 showed significant subchondral bone contact 28 which may be related to defect progression. 42 In clinical evidence consisting of prospective studies and RCTs, defect size has also been found to affect treatment choice and outcomes. A recent randomized comparative trial found that lesion size is related to the outcome of MFx but not osteochondral autograft transplantation (OAT). 26 Lesions .2 cm 2 in area demonstrated a worse International Cartilage Repair Society (ICRS) score after MFx surgery than those ,2 cm 2 (P = 0.04). A separate randomized comparative trial 27 found that among patients who underwent MFx, significantly higher postoperative Short Form 36 (SF-36) 43 scores were observed for lesions ,4 cm 2 , suggesting that MFx may be better suited for smaller lesions. Despite the size-specific outcome association with MFx, lesion size was not found to be a predictor of Lysholm scores 19 or functional outcome 29 in OAT. Additionally, outcomes of ACI measured by the Cincinnati Knee Rating System were also not affected by defect size. 18 These findings suggest that larger lesions could be treated with OAT, although limited by donor tissue availability, or ACI, whereas smaller lesions (,4 cm 2 ) could be effectively treated by any technique.
Defect Location
Intra-articular defect location was found to affect cartilage biomechanics in animal studies and defect progression in clinical studies, mostly prospective in design ( Table 2 ). Defects on the medial femoral condyle showed a tendency to progress to larger sizes and involve subchondral bone changes. 33 In a prospective study, 30 lesions located in the weight-bearing central region of the medial compartment had the highest progression in the rate of cartilage loss compared with other regions of the medial compartment and the lateral compartment. Differences in intralesional subchondral bone contact were also observed between the medial and lateral compartments. 28 In this study, the intralesional subchondral bone contact threshold differed significantly (P , 0.05) based on defect location (medial condyles = 1.99 cm 2 or lateral condyles = 1.61 cm 2 ), stressing the importance of defect location on cartilage biomechanics.
Clinical results of certain cartilage treatments are also influenced by location. In a cohort study with 55 subjects on MFx and ACI treatments, defects in the medial femoral condyle showed better improvements in Knee Injury and Osteoarthritis Outcome Score (KOOS) than lesions in the lateral femoral condyles (P , 0.05). 14 Outcome measures after MFx [Cincinnati score, ICRS, and magnetic resonance imaging (MRI) assessments] were statistically better for lesions that were on the femoral condyles versus those on tibial, trochlear, or patellar regions. 32 In contrast, ACI treatment showed successful outcomes in trochlear lesions. 31 However, OAT was shown to be unaffected by lesion location, 29 perhaps due to the viability of the intact transplanted cartilage.
Knee Alignment
Knee alignment can influence defect loading and clinical outcomes of cartilage restoration. However, the evidence summarizing these findings is not of the highest quality ( Table 3) . Two of the studies were case series, 34, 35 one was a clinical prospective study 36 but with a small sample of 14 subjects, and another was a cadaveric experiment. 37 In the cadaveric biomechanical study on unloading isolated cartilage defects through high tibial osteotomy, medial contact pressure and area both decreased as tibiofemoral alignment moved from varus to valgus alignment (P , 0.001). 37 Furthermore, between 6 and 10 degrees of anatomical-axis valgus alignment, there was complete unloading of the medial compartment. This study, along with another clinical study, 35 supports the use of corrective tibial osteotomy for medial lesions in the situation of varus malalignment. Patellofemoral alignment can also play a significant role in patellofemoral compartment loading and clinical outcomes. Pascual-Garrido et al 34 found that outcomes were improved by combining anteromedialization with ACI compared with ACI alone. Similarly, improved outcomes were found in patients who had corrective distal realignment with ACI for combined patellar cartilage lesions and patellar malalignment. 36 Therefore, improving alignment and unloading the articular cartilage in the patellofemoral joint can affect the results of restorative procedures.
Evidence for the Consideration of New Factors in Treatment Selection
Current literature suggests that patient sex and BMI may play a role in cartilage injury and repair outcomes. The role of patient age in treatment outcomes is inconclusive.
Patient Sex
There are sex differences in cartilage loss in the knee that may influence outcomes according to 2 clinical prospective studies (Table 4 ). 16, 41 Women had higher MRI-assessed annual tibial cartilage loss (1.6% vs 0.4%, P = 0.05) and higher patellar cartilage loss (2.3% vs 0.8%, P = 0.02) than men. 16 Moreover, women's risk of progression of tibiofemoral cartilage defects was higher than men (P = 0.03). This study provides compelling evidence, assessed prospectively, in a large sample of 271 patients. In the latter study, which had much fewer subjects (27) , autologous matrix-induced chondrogenesis yielded higher ICRS scores in males than in females. 41 These findings show a difference in the pattern of cartilage loss between men and women and that a difference in treatment outcome may exist between both sexes in certain treatments.
Patient Body Mass Index
Body mass index appeared to affect the outcome of defect repair as well as the incidence of defects in 2 clinical prospective studies (Table 5 ). Elevated baseline BMI, weight, waist circumference, and fat mass were found to increase the risk of the presence of patellar cartilage defects (P , 0.03) in a study of 297 patients. 40 These findings, in a sample with this magnitude, are particularly important in highlighting an association between BMI and the pathology of cartilage defects. In the only clinical study that examined BMI in relation to cartilage treatment outcomes in 48 subjects, 15 individuals with BMI .30 kg/m 2 showed lower outcome scores than those whose 
Patient Age
There was conflicting evidence on the association between patient age and outcomes of different treatments for focal cartilage defects. The evidence was mostly in prospective cohort studies with adequate samples in addition to an RCT and a case series study ( Table 6 ). In some studies, younger patients, especially ,30 years of age, showed higher postoperative improvements in KOOS, 14 27 Lysholm, 38 Hospital for Special Surgery, and ICRS scores 26 than older patients regardless of treatment (ACI, MFx, or OAT). However, conflicting findings showed that age does not significantly predict outcomes with ACI 39 or OAT. 29 
DISCUSSION
We hypothesized that patient age, BMI, and sex, defect size and location, and knee mechanical alignment are associated with cartilage lesion treatment and should be considered in an expanded algorithm for the treatment of cartilage defects. Through this systematic review, there was evidence that each of these factors may be associated with treatment choice and outcomes of cartilage defects; however, not all of the evidence was consistent. Current treatment algorithms discussed in the literature 6, 8, 9 do not address patient age, sex, BMI, or intra-articular defect location (medial vs lateral femoral condyle) as parameters affecting treatment choice. Our results suggest that some of these parameters warrant consideration in the treatment algorithm.
Defect size affected the outcome for certain cartilage techniques, but not others. It can be inferred from evidence based on RCTs 26, 27 that MFx treatment is not well suited for lesions larger than 2 to 4 cm 2 . Autologous chondrocyte implantation, however, seems to give satisfactory outcomes even in larger lesions. [44] [45] [46] This provides good support for the current algorithm and its use of a 2 to 3 cm 2 guideline for treatment selection. The range in size may relate to differences in size and shape of the condyles. 28 A smaller threshold may be appropriate for a more petite person or potentially the lateral femoral condyle. The inherent differences in the shape, Defect location not only influences the biomechanics of the defect but also influences clinical outcomes. Lateral and medial femoral condyles likely behave differently based on both biomechanical and clinical studies. 14, 28 This is because of the different geometry of the condyles and the articulating surface of the corresponding meniscus and tibial plateau. Furthermore, outcomes of certain restorative techniques are influenced by location. Microfracture seemed to be better at treating lesions in the femoral condyles than trochlear, tibial, or patellar lesions. This is secondary to the less robust repair tissue, composed primarily of fibrocartilage. 26, [47] [48] [49] In contrast, OAT and ACI outcomes do not seem to be influenced greatly by lesion location. These guidelines could be incorporated in the treatment algorithm, which currently oversimplifies the construct of lesion location to 2 groups: patellofemoral and femoral condyles.
Mechanical alignment issues are important in treatment of both tibiofemoral and patellofemoral articulations. The evidence shows that malalignment of the knee (tibiofemoral or patellofemoral) should be corrected via unloading osteotomy along with repair of cartilage defects to ensure better treatment outcomes. This backs up the claims in the existing algorithm that concomitant surgery may be needed along with cartilage repair to ensure the proper knee alignment that would favor defect repair.
The evidence on the role of patient age in the outcome of cartilage treatments was inconclusive, despite the presence of multiple studies with prospective designs. It seemed that in general, those younger than 30 years old had more favorable outcomes than those older (in both MFx and ACI). This is supported by current systematic review evidence. 44 Although other comparisons of age show no difference in outcomes after ACI or OAT, these studies lack the methodological strength of the studies showing an effect of age, which have larger samples and include prospective and randomized trials. It is likely that age affects all procedures of the knee, reflecting the degenerative process and the declining healing potential that progress with age. However, it is possible that the influence of age may not have as much of an effect on OAT and ACI because of the improved mechanical properties of the repair tissue.
Patient sex and BMI both appeared to be associated with cartilage breakdown and treatment outcome, which may have important clinical implications. However, although compelling due to prospective design and reasonably large samples, the evidence on the effect of these factors on treatments is limited to 2 studies for either factor. Although sex is not extensively studied in association with treatment outcomes, the existing studies show that women have shown higher cartilage loss rates and risk of progression of cartilage defects than men. 16, [50] [51] [52] The sex effect on cartilage warrants further investigation into what cartilage structural or biomechanical properties are behind this finding and how they affect outcomes. With obesity becoming an epidemic in both Western and non-Western societies, the understanding of how BMI affects specific cartilage treatment is paramount. Further research is needed in both these areas to understand how to maximize treatment alternatives based on sex and BMI.
Although the discussed evidence points to the importance of including more factors in the treatment algorithm, a clear set of guidelines in treatment selection based on these factors must be established. The evidence only gives a general logic of how these other factors (sex, BMI, defect intraarticular location) may be used as guidelines. These findings merely suggest the importance of considering these factors in an expanded treatment algorithm, but stronger evidence with more clinical prospective studies is needed to know which treatment is best for each set of conditions.
Limitations
The quality of the evidence summarized in this review is an important limitation to the findings. Although some of the evidence is based on RCTs (level I evidence) and prospective cohort studies (level II), there are also lowerlevel evidence designs included (case series, animal, and cadaver experiments). Moreover, the populations studied are heterogeneous, and the study outcomes are measured through various methods, limiting our ability to compare results and extrapolate data to general populations. Some of the outcome measures used in the studies may also face validity criticism. The only validated scores for treatment of knee chondral injury are KOOS, IKDC, and Lysholm scores. 53, 54 Cincinnati and Tegner activity scores are validated for other procedures but not cartilage treatment. [55] [56] [57] In the included and reviewed studies, follow-up duration was highly variable, making it difficult to compare findings. Finally, some of the studies scrutinized do not discuss the direct effect of many or all of the specific factors of interest on cartilage lesion treatment. More research is needed to address the direct relationships between treatment outcomes and the patient-specific, kneespecific, and defect-specific factors in this systematic review.
CONCLUSIONS
Choice of the appropriate repair or restoration technique for focal cartilage defects in the knee is multifactorial. A treatment algorithm should consider already commonly used factors such as defect size, location, knee alignment, and patient demand. However, patient sex and BMI should also be considered in this algorithm. Patient age was not significantly associated with clinical outcome.
